Skip to main content
SpringerLink
Log in

A Response to the “Call to Action” on Pathologic Reporting of Lymph Node Metastases in Differentiated Thyroid Cancer from the College of American Pathologists

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Urken ML, Mechanick JI, Sarlin J, Scherl S, Wenig BM. Pathologic Reporting of Lymph Node Metastases in Differentiated Thyroid Cancer: a Call to Action for the College of American Pathologists. Endocr Pathol, 2013.

  2. Randolph GW, Duh QY, Heller KS et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22: 1144-1152, 2012.

    Article  PubMed  Google Scholar 

  3. Leboulleux S, Rubino C, Baudin E et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90: 5723-5729, 2005.

    Article  CAS  PubMed  Google Scholar 

  4. Ito Y, Hirokawa M, Jikuzono T et al. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31: 1194-1201, 2007.

    Article  PubMed  Google Scholar 

  5. Spires JR, Robbins KT, Luna MA, Byers RM. Metastatic papillary carcinoma of the thyroid: the significance of extranodal extension. Head Neck 11: 242-246, 1989.

    Article  CAS  PubMed  Google Scholar 

  6. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80: 2268-2272, 1997.

    Article  CAS  PubMed  Google Scholar 

  7. Washington MK, Baker TP, Simpson J. Checklists, protocols, and the “gold standard” approach. Arch Pathol Lab Med 138: 159-160, 2014.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Raja R. Seethala

  2. The Joint Pathology Center, Bethesda, MD, USA

    Thomas P. Baker

  3. Breast Pathology Consultants, Inc., Nashville, TN, USA

    Jean F. Simpson

  4. University of South Alabama, Mobile, AL, USA

    Jean F. Simpson

Authors
  1. Raja R. Seethala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas P. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean F. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raja R. Seethala.

Additional information

The opinions or assertions contained herein are the private views of the author and do not reflect the official policy of the Department of the Army, Department of Defense, or the United States government.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seethala, R.R., Baker, T.P. & Simpson, J.F. A Response to the “Call to Action” on Pathologic Reporting of Lymph Node Metastases in Differentiated Thyroid Cancer from the College of American Pathologists. Endocr Pathol 25, 441–442 (2014). https://doi.org/10.1007/s12022-014-9324-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-014-9324-9

Keywords

Search

Navigation